Certain statements in this release constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, economic, competitive, governmental, and technological factors affecting the Company's operations, markets, products, services, and prices.Contact:
D. Michael Parker704/871-3290 Kewaunee Scientific CorporationConsolidated Statements of Operations (Unaudited)(in thousands, except per share data)Three months endedJuly 31,20132012Net sales$
26,683Cost of products sold25,42721,440Gross profit6,5765,243Operating expenses4,1444,138Operating earnings2,4321,105Other income8068Interest expense(88)(114)Earnings before income taxes2,4241,059Income tax expense807371Net earnings1,617688Less: net earnings attributable to the noncontrolling interest3054Net earnings attributable to Kewaunee Scientific Corporation$
34Net earnings per share attributable toKewaunee Scientific Corporation stockholdersBasic$0.61$0.25Diluted$0.61$0.25Weighted average number of common shares outstandingBasic2,5962,581Diluted2,6182,584Kewaunee Scientific CorporationCondensed Consolidated Balance Sheets(in thousands)July 31,April 30,20132013Assets(Unaudited)Cash and cash equivalents$4,408$5,811Restricted Cash619691Receivables, less allowances24,75225,884Inventories12,33413,203Pr
|SOURCE Kewaunee Scientific Corporation|
Copyright©2012 PR Newswire.
All rights reserved